$VTEX

VTEX Q2 Earnings Call Highlights

VTEX (NYSE:VTEX) reported Q2 margin and cash flow improvement and guided for Q3 and full-year low-single-digit FX-neutral subscription revenue growth and low-20% non-GAAP operating and free cash flow margins. Q2 non-GAAP subscription gross margin rose to 81.8%. Free cash flow rose 79% to $12.7M. VTEX repurchased 6.2M shares at $3.76.

Original reporting
Published Aug 9, 2026, 3:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 9, 2026, 3:52 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
VTEX Q2 Earnings Call Highlights — source image
Decision brief

The 30-second read

$VTEXNeutralMed
01

Why it matters

Traders can update expectations for VTEX’s growth trajectory (flat Q3 FX-neutral subscription growth) versus profitability (gross margin and operating margin expansion) and assess whether the share repurchase supports downside in a slower-consumption environment.

02

Market read

The key tradable update is the combination of flat Q3 FX-neutral subscription growth guidance and low-20% margin/free-cash-flow targets, alongside improved gross margin and a $23.2M buyback.

03

What to watch

AI Workspace is on a wait list and not yet contributing financially, so upside may be delayed; also, the company did not provide a specific launch date for near-term AI field-sales tools.

Relevance 8/10Novelty 7/10Timing: post-call, for positioning ahead of next earnings/updates

Background

VTEX held its Q2 earnings call and provided updated Q3 and full-year FX-neutral guidance, plus commentary on AI, ads, and B2B growth drivers.

Company-level read

Ticker impact

$VTEXNeutralMedium confidence
Context

VTEX guided Q3 to flat FX-neutral subscription revenue growth and low-single-digit FX-neutral gross profit growth, plus low-20% margin targets.

Expected impact

Near-term volatility likely around whether investors view margin expansion and buyback as offsetting slower growth.

Evidence & confidence

The article provides fresh, specific forward guidance (Q3 and full-year) and updated FX assumptions, alongside margin and free-cash-flow expansion and a sizable share repurchase.

Market effects

Commerce SaaS peers may be read through on how AI automation and partner ecosystems can support margins even when consumption softens.

Brazil demand softness is explicitly cited as a driver of the weaker growth trend, which can affect sentiment for LATAM-focused software names.

FX sensitivity is quantified (FX effects add ~7 pp to Q3 and ~8.1 pp full-year), which can influence how investors normalize results across regions.

Counterpoint

Margin and free-cash-flow improvement could be partly mix-driven (lower services emphasis) and may not persist if enterprise mix shift slows.

Key entities

  • VTEX

    Global commerce platform provider; issued Q3 and full-year FX-neutral guidance and reported margin and cash-flow expansion in Q2.

  • OBI

    German customer whose long-term partnership was renewed and described as a key reference in Europe.

  • Whirlpool

    Cited example of B2B expansion in Brazil supporting VTEX’s B2B growth narrative.

Related articles

$VTEXMed

VTEX (VTEX) Just Turned A Profit Corner, But Growth Is Slowing

VTEX (NYSE:VTEX) reported Q2 2026 results showing improved profitability with non-GAAP income from operations up 62.4% YoY to $13.8M, and free cash flow up 79.1% to $12.7M. However, revenue growth slowed to 1.3% YoY on an FX-neutral basis, with management expecting flat growth for Q3. The company repurchased 6.2M shares for $23.2M during the quarter.

$VTEXMedAI 8/10

VTEX (VTEX) Q2 2026 Earnings Call Transcript

VTEX reported Q2 2026 results in an earnings call. GMV was $5.7B, up 7% FX-neutral. Subscription revenue was $63.8M, up 1.3% FX-neutral. Non-GAAP operating income rose 62% to $13.8M, with a 21.4% margin. Free cash flow was $12.7M, up 79%. Q3 guidance calls for flat FX-neutral subscription growth.

$VTEXMed

VTEX (VTEX): Financial results for Q2 2026

VTEX (VTEX) furnished an SEC Form 6-K — earnings release. VTEX Reports Second Quarter 2026 Financial Results Subscription revenue grew 11.4% (+1.3% FXN), with GMV up 17.8% (+7.0% FXN) Non-GAAP income from operations increased 62.4% to US$13.8 million, reaching a 21.4% margin Free cash flow increased 79.1% to US$12.7 million, reaching a

$NKEMedAI 8/10

Nike Gets Booted From S&P 100 After Losing 80% of Its Value

Nike (NKE) will be removed from the S&P 100 on Sept. 21 after an 18-year run, with its stock down 75% over five years. Q4 FY26 earnings included a one-time $986M benefit, with underlying EPS at $0.20. Revenue declined to $46.4B in FY26, and management expects further declines. Analysts have cut fiscal 2027 EPS estimates to $1.72. Morgan Stanley resumed coverage with an Underweight rating and $31 target.

$ORCLMedAI 8/10

Oracle earnings read-throughs: cloud rivals, AI suppliers, and hyperscalers to watch

Oracle (ORCL) reports earnings on September 10, with consensus estimates at $1.73 EPS and $19.13B revenue. Investors focus on cloud infrastructure demand, AI spending, and rival cloud platforms. Oracle's backlog is $638B, with fiscal 2027 net capex guidance of $70B–$95B. Mizuho expects 1GW of new OCI capacity and maintains a $320 price target. Competitors like Microsoft (MSFT), Alphabet (GOOGL), NVIDIA (NVDA), Broadcom (AVGO), and Cisco (CSCO) may be impacted by Oracle's results.